The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDP.L Regulatory News (IDP)

  • There is currently no data for IDP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

19 Dec 2016 15:18

RNS Number : 2747S
InnovaDerma PLC
19 December 2016
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

 

 

1. Identity of the issuer or the underlying issuer

of existing shares to which voting rights are

attached: ii

 

 

 

InnovaDerma Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

3. Full name of person(s) subject to the

notification obligation: iii

 

 

Jenepé Limited

 

4. Full name of shareholder(s)

(if different from 3.):iv

 

 

N/a

5. Date of the transaction and date on

which the threshold is crossed or reached: v

 

 

16th December 2016

6. Date on which issuer notified:

19th December 2016

7. Threshold(s) that is/are crossed or reached: vi, vii

 

3%

 

    

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of shares

 

if possible using

the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights x

 

Direct

 

Direct xi

Indirect

xii

 

Direct

 

Indirect

 

GB00B92JR 174

 

 

136,551

 

136,551

 

417,631

 

417,631

 

 

N/a

 

 

3.76%

 

 

N/a

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial

Expirati

Exercise/

Number of voting

% of voting

instrument

on

Conversion

rights that may be

rights

 

date xiii

Period xiv

acquired if the

 

 

 

 

instrument is

 

 

 

 

exercised/

 

 

 

 

converted.

 

 

N/a

 

N/a

 

N/a

 

N/a

 

N/a

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of

Exercis

Expirat

Exercise/

Number of voting

% of voting

financial

e price

ion

Conversio

rights instrument

rights xix, xx

instrument

 

date xvii

n period

refers to

 

 

 

 

xviii

 

 

 

N/a

 

N/a

 

N/a

 

N/a

 

 

N/a

Nominal

Delta

N/a

N/a

Total (A+B+C)

Number of voting rights

Percentage of voting rights

417,631

3.76%

 

9. Chain of controlled undertakings through which the voting rights and/ or the financial instruments are effectively held, if applicable: xxi

N/a

Proxy Voting:

10. Name of the proxy holder:

N/a

11. Number of voting rights proxy holder will cease to hold:

 

N/a

12. Date on which proxy holder will cease to hold voting rights:

 

N/a

 

 

 

13. Additional information:

 

14. Contact name:

Terry Richards

 

15. Contact telephone number:

 

+61 408 123 401

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBUBDDUBBBGLC
Date   Source Headline
15th Oct 20202:00 pmRNSPrice Monitoring Extension
30th Sep 20207:00 amRNSFinal Results
28th Sep 20207:00 amRNSUS distributor appointed and Nuthing launch in AUS
18th Sep 20207:00 amRNSNotice of Results and Presentation
1st Sep 20209:37 amRNSHolding(s) in Company
12th Aug 202010:58 amRNSHolding(s) in Company
5th Aug 20209:15 amRNSDirectorate Change
31st Jul 202010:22 amRNSHolding(s) in Company
13th Jul 20209:40 amRNSHolding(s) in Company
10th Jul 20207:00 amRNSTrading Statement
1st Jul 202010:10 amRNSHolding(s) in Company
12th Jun 20205:57 pmRNSHolding(s) in Company
26th May 20207:00 amRNSTrading Statement
13th May 20204:42 pmRNSHolding(s) in Company
7th May 202010:52 amRNSDirector/PDMR Shareholding
6th May 202010:05 amRNSHolding(s) in Company
4th May 202011:09 amRNSHolding(s) in Company
30th Apr 202011:05 amRNSSecond Price Monitoring Extn
30th Apr 202011:00 amRNSPrice Monitoring Extension
6th Apr 20202:05 pmRNSSecond Price Monitoring Extn
6th Apr 20202:00 pmRNSPrice Monitoring Extension
6th Apr 20207:00 amRNSCOVID-19 Update
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
18th Mar 20201:56 pmRNSDirector/PDMR Shareholding
17th Mar 20201:52 pmRNSHolding(s) in Company
16th Mar 202012:54 pmRNSDirector/PDMR Shareholding
12th Mar 20202:37 pmRNSDirector/PDMR Shareholding
12th Mar 202011:06 amRNSSecond Price Monitoring Extn
12th Mar 202011:00 amRNSPrice Monitoring Extension
3rd Mar 202010:47 amRNSDirector/PDMR Shareholding
25th Feb 202011:52 amRNSHalf-year Report- Replacement
25th Feb 20207:00 amRNSHalf-year Report
24th Feb 20207:00 amRNSInnovaDerma launches new brand "Nuthing"
3rd Feb 20207:00 amRNSNotice of Results
23rd Jan 20208:48 amRNSGrant of Options/PDMR Dealing
9th Jan 20207:00 amRNSTrading Statement
5th Dec 20197:00 amRNSDTC channel delivers best Black Friday weekend
29th Nov 20192:26 pmRNSDirector/PDMR Shareholding
28th Nov 20193:21 pmRNSDirector/PDMR Shareholding
20th Nov 20197:00 amRNSLaunch of new Skinny Tan 'Choc' range in Superdrug
13th Nov 201912:39 pmRNSDirector/PDMR Shareholding
8th Nov 20193:40 pmRNSDirector/PDMR Shareholding
8th Nov 20193:22 pmRNSDirector/PDMR Shareholding
7th Nov 20192:33 pmRNSHolding(s) in Company
7th Nov 20191:55 pmRNSHolding(s) in Company
7th Nov 20191:53 pmRNSDirector/PDMR Shareholding
7th Nov 20191:47 pmRNSDirectorate Change
6th Nov 201911:01 amRNSResult of AGM
6th Nov 20197:00 amRNSAGM Statement
31st Oct 20197:00 amRNSLaunch of new category in Superdrug

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.